title: Aptamers: multifunctional molecules for biomedical research.
abstract: Aptamers are single-stranded oligonucleotides that fold into well-defined three-dimensional shapes, allowing them to bind their targets with high affinity and specificity. They can be generated through an in vitro process called "Systemic Evolution of Ligands by Exponential Enrichment" and applied for specific detection, inhibition, and characterization of various targets like small organic and inorganic molecules, proteins, and whole cells. Aptamers have also been called chemical antibodies because of their synthetic origin and their similar modes of action to antibodies. They exhibit significant advantages over antibodies in terms of their small size, synthetic accessibility, and ability to be chemically modified and thus endowed with new properties. The first generation of aptamer drug "Macugen" was available for public use within 25 years of the discovery of aptamers. With others in the pipeline for clinical trials, this emerging field of medical biotechnology is raising significant interest. However, aptamers pose different problems for their development than for antibodies that need to be addressed to achieve practical applications. It is likely that current developments in aptamer engineering will be the basis for the evolution of improved future bioanalytical and biomedical applications. The present review discusses the development of aptamers for therapeutics, drug delivery, target validation and imaging, and reviews some of the challenges to fully realizing the promise of aptamers in biomedical applications.
authors.affiliation: Biology Department, Indian Institute of Science Education and Research (IISER), 900 NCL Innovation Park, Dr. Homi Bhabha Road, Pune, 411008, India, jayeetab@iiserpune.ac.in.
authors.forename: Jayeeta
authors.initials: J
authors.lastname: Banerjee
authors.forename: Marit
authors.initials: M
authors.lastname: Nilsen-Hamilton
mesh_terms: D000818:Animals; D052157:Aptamers, Nucleotide / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D035843:Biomedical Research; D016503:Drug Delivery Systems; D055808:Drug Discovery; D006801:Humans; D008024:Ligands; D052156:SELEX Aptamer Technique
chemical_list: D052157:Aptamers, Nucleotide; D008024:Ligands
references.citation: Biol Chem. 2009 Feb;390(2):137-44
references.pmid: 19040357
references.citation: Mol Ther Nucleic Acids. 2013 Jan 08;2:e67
references.pmid: 23299833
references.citation: Chemistry. 2003 Mar 3;9(5):1137-45
references.pmid: 12596150
references.citation: J Virol. 1996 Jan;70(1):179-87
references.pmid: 8523524
references.citation: Nano Lett. 2008 Dec;8(12):4210-6
references.pmid: 19367962
references.citation: Cancer Res. 2006 Jun 15;66(12):5989-92
references.pmid: 16778167
references.citation: Anal Chem. 2005 Jan 15;77(2):442-8
references.pmid: 15649039
references.citation: Ann Thorac Surg. 1994 Aug;58(2):344-50
references.pmid: 8067830
references.citation: Bioorg Med Chem. 2001 Oct;9(10):2525-31
references.pmid: 11557339
references.citation: Blood. 1999 Jul 1;94(1):368-71
references.pmid: 10381536
references.citation: J Am Chem Soc. 2002 Aug 21;124(33):9678-9
references.pmid: 12175205
references.citation: Anal Chem. 2011 Mar 1;83(5):1523-9
references.pmid: 21291178
references.citation: Exp Biol Med (Maywood). 2006 Feb;231(2):204-14
references.pmid: 16446497
references.citation: Pharmaceuticals (Basel). 2011 Oct 27;4(11):1434-1449
references.pmid: 27721331
references.citation: Chembiochem. 2005 Dec;6(12):2163-6
references.pmid: 16254932
references.citation: Science. 2000 Feb 4;287(5454):820-5
references.pmid: 10657289
references.citation: J Virol. 2005 Nov;79(21):13806-10
references.pmid: 16227301
references.citation: Comb Chem High Throughput Screen. 2008 Jan;11(1):16-23
references.pmid: 18220540
references.citation: Nucleic Acids Res. 2006 Jun 01;34(10):e73
references.pmid: 16740739
references.citation: Anal Chem. 2009 Sep 1;81(17):7436-42
references.pmid: 19715365
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15908-13
references.pmid: 18838694
references.citation: Nat Biotechnol. 2009 Sep;27(9):839-49
references.pmid: 19701187
references.citation: Methods. 2013 Sep 15;63(2):178-87
references.pmid: 23535583
references.citation: Nature. 1990 Mar 29;344(6265):467-8
references.pmid: 1690861
references.citation: Sci Transl Med. 2011 Jan 19;3(66):66ra6
references.pmid: 21248316
references.citation: Handb Exp Pharmacol. 2008;(181):343-73
references.pmid: 18071953
references.citation: J Am Chem Soc. 2008 Mar 19;130(11):3244-5
references.pmid: 18293973
references.citation: Int J Mol Sci. 2012;13(3):3341-53
references.pmid: 22489154
references.citation: Nucleic Acids Res. 2012 Apr;40(7):3117-30
references.pmid: 22139931
references.citation: Biosens Bioelectron. 2009 Jul 15;24(11):3175-82
references.pmid: 19117748
references.citation: Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
references.pmid: 21441582
references.citation: Anal Chem. 2012 Oct 16;84(20):8763-70
references.pmid: 22946879
references.citation: Nucleic Acids Res. 2009 Feb;37(3):866-76
references.pmid: 19103663
references.citation: Angew Chem Int Ed Engl. 2006 Dec 4;45(47):7955-9
references.pmid: 17094149
references.citation: Exp Mol Pathol. 2009 Jun;86(3):151-64
references.pmid: 19454272
references.citation: Nat Rev Cancer. 2004 Oct;4(10):806-13
references.pmid: 15510161
references.citation: Anal Chim Acta. 2013 Jan 3;758:130-7
references.pmid: 23245905
references.citation: Anal Chem. 2007 Jun 1;79(11):4120-5
references.pmid: 17477504
references.citation: Discov Med. 2011 Jun;11(61):487-96
references.pmid: 21712014
references.citation: Arch Pharm Res. 2012 Oct;35(10):1693-9
references.pmid: 23139119
references.citation: J Am Chem Soc. 2009 Aug 12;131(31):11174-8
references.pmid: 19603808
references.citation: Cancer Res. 2008 Apr 1;68(7):2358-65
references.pmid: 18381443
references.citation: FEBS Lett. 2003 Jul 31;548(1-3):85-9
references.pmid: 12885412
references.citation: Nucleic Acids Res. 2008 Dec;36(22):7124-35
references.pmid: 18996899
references.citation: Angew Chem Int Ed Engl. 2009;48(35):6494-8
references.pmid: 19623590
references.citation: Chemistry. 2008;14(6):1769-75
references.pmid: 18092308
references.citation: Cancer Res. 2010 Nov 1;70(21):8617-29
references.pmid: 20861190
references.citation: Science. 1990 Aug 3;249(4968):505-10
references.pmid: 2200121
references.citation: Can J Microbiol. 2011 Jun;57(6):453-9
references.pmid: 21627466
references.citation: ACS Nano. 2008 Oct 28;2(10):2023-8
references.pmid: 19206447
references.citation: J Biomol Tech. 2005 Sep;16(3):224-34
references.pmid: 16461946
references.citation: Cancer Res. 2012 Mar 15;72(6):1373-83
references.pmid: 22282665
references.citation: Front Genet. 2012 Nov 02;3:234
references.pmid: 23130020
references.citation: Leukemia. 2009 Feb;23(2):235-44
references.pmid: 19151784
references.citation: Virology. 1995 Jun 1;209(2):327-36
references.pmid: 7778267
references.citation: J Virol. 2012 May;86(9):4989-99
references.pmid: 22379083
references.citation: Anal Chem. 2003 Apr 15;75(8):1861-7
references.pmid: 12713044
references.citation: Gene Ther. 2007 Feb;14(4):283-91
references.pmid: 17279100
references.citation: Nano Lett. 2007 Oct;7(10):3065-70
references.pmid: 17854227
references.citation: Anal Chem. 2008 Feb 1;80(3):567-72
references.pmid: 18166023
references.citation: Nature. 1990 Aug 30;346(6287):818-22
references.pmid: 1697402
references.citation: Mol Biol Rep. 2012 Mar;39(3):2157-62
references.pmid: 21643749
references.citation: Cell Mol Life Sci. 2009 Aug;66(15):2445-55
references.pmid: 19396399
references.citation: Adv Exp Med Biol. 2013;735:283-300
references.pmid: 23402035
references.citation: Eur J Pharm Sci. 2013 Jan 23;48(1-2):259-71
references.pmid: 23142634
references.citation: Clin Chem. 1999 Sep;45(9):1628-50
references.pmid: 10471678
references.citation: Front Microbiol. 2012 Feb 08;3:29
references.pmid: 22347221
references.citation: Nat Biotechnol. 2004 Nov;22(11):1423-8
references.pmid: 15502817
references.citation: Indian J Med Sci. 2010 Mar;64(3):144-7
references.pmid: 22569328
references.citation: Virology. 2008 Nov 10;381(1):46-54
references.pmid: 18799178
references.citation: Chem Commun (Camb). 2006 Sep 28;(36):3780-2
references.pmid: 16969455
references.citation: Curr Med Chem. 2011;18(27):4206-14
references.pmid: 21838685
references.citation: Chem Commun (Camb). 2010 Aug 14;46(30):5566-8
references.pmid: 20407731
references.citation: Chem Commun (Camb). 2008 Jun 14;(22):2520-2
references.pmid: 18506230
references.citation: Nucleic Acids Res. 2008 Dec;36(21):6739-51
references.pmid: 18948292
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3606-10
references.pmid: 10097084
references.citation: J Am Chem Soc. 2006 Dec 13;128(49):15584-5
references.pmid: 17147356
references.citation: RNA. 2011 Jan;17(1):182-8
references.pmid: 21097555
references.citation: Nature. 2007 Dec 20;450(7173):1263-7
references.pmid: 18097416
references.citation: Hamostaseologie. 2011 Nov;31(4):258-63
references.pmid: 22065102
references.citation: Blood. 2011 Jan 13;117(2):727-35
references.pmid: 20926770
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:151-71
references.pmid: 17145936
references.citation: Angew Chem Int Ed Engl. 2010 Aug 16;49(35):6216-9
references.pmid: 20632338
references.citation: Curr Cancer Drug Targets. 2008 Nov;8(7):554-65
references.pmid: 18991566
references.citation: Mol Ther. 2009 Jan;17(1):153-61
references.pmid: 18985031
references.citation: Curr Opin Chem Biol. 2006 Jun;10(3):282-9
references.pmid: 16621675
references.citation: PLoS One. 2012;7(4):e36103
references.pmid: 22536456
references.citation: Nucleic Acids Res. 2011 Oct;39(18):8237-47
references.pmid: 21727088
references.citation: Langmuir. 2007 Jan 30;23(3):1300-2
references.pmid: 17241049
references.citation: ChemMedChem. 2007 Sep;2(9):1268-71
references.pmid: 17600796
references.citation: Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5
references.pmid: 18674538
references.citation: Nat Biotechnol. 2006 Aug;24(8):1005-15
references.pmid: 16823371
references.citation: Pharmaceuticals (Basel). 2010 May 27;3(6):1761-1778
references.pmid: 27713328
references.citation: Oncoimmunology. 2013 Apr 1;2(4):e24117
references.pmid: 23734336
references.citation: J Mol Biol. 2012 Oct 5;422(5):595-606
references.pmid: 22721953
references.citation: J Nucleic Acids. 2011;2011:904750
references.pmid: 21904667
references.citation: ACS Nano. 2010 Sep 28;4(9):5101-10
references.pmid: 20704275
references.citation: Nat Chem Biol. 2010 Jan;6(1):22-4
references.pmid: 19946274
references.citation: J Biotechnol. 2000 Mar;74(1):27-38
references.pmid: 10943570
references.citation: J Med Chem. 2009 Aug 27;52(16):5108-14
references.pmid: 19650625
references.citation: Nucleic Acids Symp Ser. 1995;(34):145-6
references.pmid: 8841594
references.citation: Chem Commun (Camb). 2007 Sep 28;(36):3735-7
references.pmid: 17851611
references.citation: Oligonucleotides. 2009 Jun;19(2):117-28
references.pmid: 19284310
references.citation: J Ocul Pharmacol Ther. 2007 Oct;23(5):452-66
references.pmid: 17900226
references.citation: Science. 2006 Feb 3;311(5761):653-6
references.pmid: 16456078
references.citation: ChemMedChem. 2012 Jan 2;7(1):79-84
references.pmid: 22170627
references.citation: Chem Commun (Camb). 2010 Jan 14;46(2):249-51
references.pmid: 20024341
references.citation: Oligonucleotides. 2008 Jun;18(2):133-44
references.pmid: 18637731
references.citation: Parasitol Res. 2009 Nov;105(6):1557-66
references.pmid: 19693540